Private equity firms to acquire health care billing and payments firm R1 in $8.9 billion deal

R1 RCM is finally getting taken off the public markets, ending a months-long saga between private equity firms that were trying to take control of the large health care billing and collections company.

Private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice are teaming up to buy R1, the companies said Thursday. TowerBrook, in a partnership with the Catholic hospital system Ascension, already owns 36% of R1 — which made TowerBrook and Ascension the company’s largest combined shareholder. TowerBrook and CD&R are buying the rest of the company for $14.30 per share in cash, valuing R1 at $8.9 billion.

The bidding war for R1 highlights private equity’s appetite for “revenue cycle management” companies, which run the medical billing, collections, patient registration, and other administrative services for hospitals and physician groups.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In